---
title: Patients Rising Signs onto LEAD Coalition Letter in Support of Drugs Such As Donanemab - Patients Rising
description: Patients Rising Now has signed onto the Leaders Engaged on Alzheimer’s Disease (LEAD) Coalition’s letter to the FDA's Drugs Advisory Committee members and Designated Federal Officer in support of the need for drugs such as donanemab.
---

[Patients Rising Blog | Patient Stories, Policy Insights & News ](https://www.patientsrising.org/advocacy-updates)

# [Patients Rising Signs onto LEAD Coalition Letter in Support of Drugs Such As Donanemab - Patients Rising](https://www.patientsrising.org/advocacy-updates/patients-rising-signs-onto-lead-coalition-letter-in-support-of-drugs-such-as-donanemab)

 Written by [Admin](https://www.patientsrising.org/advocacy-updates/author/admin) | June 20, 2024 at 4:00 PM

Patients Rising has signed onto the Leaders Engaged on Alzheimer’s Disease (LEAD) Coalition’s letter to the FDA’s Drugs Advisory Committee members and Designated Federal Officer in support of the need for drugs such as donanemab. This letter doesn’t take a formal stance on whether donanemab should be approved to treat early Alzheimer’s but encourages the FDA to carefully consider the views of patients, caregivers, doctors, and researchers. It trusts the FDA’s ability to thoroughly review the drug’s safety and effectiveness.

It further states that while donanemab isn’t a cure for Alzheimer’s, it could become a valuable option for slowing the progression of the disease. In a major study, it was shown to help people with early Alzheimer’s maintain their memory, independence, and ability to do daily activities longer than those who didn’t take the drug. The benefits were greatest for those treated early in the disease.

Although there are some risks, like a low chance of certain side effects, the letter suggests these should be managed between patients and their doctors. Overall, it argues that donanemab could offer patients and their families more precious time and improved quality of life.

[**Read the letter**](https://www.patientsrising.org/wp-content/uploads/2024/11/lead-070724.pdf)

 

[View full post](https://www.patientsrising.org/advocacy-updates/patients-rising-signs-onto-lead-coalition-letter-in-support-of-drugs-such-as-donanemab)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Admin"
  },
  "dateModified" : "2025-12-29T21:24:30.058Z",
  "datePublished" : "2024-06-20T16:00:00Z",
  "headline" : "Patients Rising Signs onto LEAD Coalition Letter in Support of Drugs Such As Donanemab",
  "image" : {
    "@type" : "ImageObject",
    "height" : 565,
    "url" : "https://6015202.fs1.hubspotusercontent-na1.net/hubfs/6015202/Medications-1.jpg",
    "width" : 847
  },
  "mainEntityOfPage" : "https://www.patientsrising.org/advocacy-updates/patients-rising-signs-onto-lead-coalition-letter-in-support-of-drugs-such-as-donanemab",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Patients. Policy. Progress."
  }
}
```